Repeat: Up to 10,000 women a year could benefit from the drug pertuzumab which today gets a licence for use in Britain from the European Medicines Agency.
Up to 10,000 women a year could benefit from the drug pertuzumab which today gets a licence for use in Britain from the European Medicines Agency.